U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. Jinghai Yi
  1. Science & Research (NCTR)

Jinghai Yi Ph.D.

Staff Fellow — Division of Biochemical Toxicology

Dr. Jinghai Yi

Jinghai Yi, Ph.D.
(870) 543-7121
NCTRResearch@fda.hhs.gov  

Back to NCTR Principal Investigators page

About  |  Publications | Lab Members

Background

Dr. Jinghai Yi received B.A., M.S., and Ph.D. degrees in energy and power engineering from Xi’an Jiaotong University in Xi’an, China. After graduating, he worked for the Power Machinery Engineering Department of Shanghai Jiaotong University in Shanghai, China, as a lecturer and postdoctoral fellow. He continued his research in the Mechanical Engineering School at Technion-Israel Institute of Technology and Purdue University and in the Petroleum Engineering Department at Louisiana State University. He was hired as a mechanical engineer at Doty Scientific, Inc. before joining BioTechPlex as a senior mechanical engineer. Dr. Yi was then hired as a senior inhalation engineer for the Technical Research Institute, a subsidiary of Illinois Institute of Technology (IIT) Research Institute. The Research Institute operates the Inhalation Facility and Animal Facility at Philip Morris International, Inc. Dr. Yi then became a research assistant professor and inhalation engineer at West Virginia University before joining the FDA as a mechanical engineer in 2017. Dr. Yi is a staff fellow and senior inhalation toxicologist in the Center for Tobacco Products (CTP)/National Center for Toxicological Research (NCTR) Inhalation Toxicology Core Facility, in NCTR’s Division of Biochemical Toxicology.

Dr. Yi received a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant and an NIH National Institute for Occupational Safety and Health (NIOSH) subcontract. He was awarded the Lila Albin Paper Award for 2017 (co-author) and the ”Best Paper of the Year” Award for Particle and Fibre Toxicology for 2019 (co-author).  He has also been awarded two U.S. patents and one Chinese patent.

 

Research Interests

Dr. Yi’s research interests include inhalation toxicology; aerosol generation and characterization; and design, fabrication, setup, validation, and operation of whole-body and nose-only inhalation exposure systems. He conducts inhalation studies in collaboration with CTP to characterize and quantify the health risks associated with selected chemicals found in tobacco products.

Dr. Yi’s awards and research projects are listed below.

  • “Best Paper of the Year” award for Particle and Fibre Toxicology for 2019 (co-author)
  • Lila Albin Paper Award for 2017 (co-author)
  • Principle Investigator (PI), Support and Infrastructure for CTP/NCTR Inhalation Facility, FDA Center for Tobacco Products (CTP), 09/2017 – 09/30/2026
  • PI, Pharmacokinetic Analysis of Nicotine in Sprague-Dawley Rats, FDA Center for Tobacco Products, 11/2017 – ongoing
  • Consultant of a NIH SBIR grant, Aerosol Delivery of Surfactant for ARDS, 1R43HL127834-01, 09/2015 – 05/2016 (PI: Yeates)
  • PI of a NIOSH contract, Inhalation Facility of Desktop 3D Printer Emissions, Contract No. 212-2015-M-63382, 08/2015 – 08/2016
  • Co-investigator of a NIOSH contract, Cardiovascular Effect of Desktop 3D Printer Emissions, 08/2015 – 08/2016
  • PI of a NIH SBIR grant, Ultra-High Dose Rate Aerosol Drug Delivery, R43HL078281-01, 12/2004 – 12/2005
  • Co-investigator of a NIH SBIR grant, Concentrated Aerosol Delivery and Quantization System 09/2001 – 07/2004. (PI: Yeates)
  • Co-investigator of a NIH SBIR grant, Water and Ion Measurement System, 5R44HL067008, (PI: Wong)
  • Co-investigator of a NIH SBIR grant, 2R44RR015150-02A1 (PI: Mao)

 

Professional Societies/National and International Groups

Society of Toxicology
Member
2009 – 2014

 

Selected Publications

Multi-Instrument Assessment of Fine and Ultrafine Titanium Dioxide Aerosols.
Ranpara A., LeBouf R.F., Nurkiewicz T.R., Yi J., Cumpston J.L., and Stefaniak A.B. 
J Toxicol Environ Health A. 2023, 86(1):1-22. doi: 10.1080/15287394.2022.2150730. Epub 2022 Nov 29. PMID: 36444639.

Fluidic and Thermal Properties of Heliox Enable the Efficient Generation and Delivery of High Concentrations of Solid-Phase, Fine Particle Aerosols from Viscous Liquids.
Heng X., Yi J., and Yeates D.
Aerosol Science and Technology. 2019, (ja), p.1-24, doi: 10.1080/02786826.2019.1584388.

Particle and Organic Vapor Emissions from Children's 3-D Pen and 3-D Printer Toys. 
Yi J., Duling M.G., Bowers L.N., Knepp A.K., LeBouf R.F., Nurkiewicz T.R., Ranpara A., Luxton T., Martin S.B. Jr., Burns D.A., Peloquin D.M., Baumann E.J., Virji M.A., and Stefaniak A.B. 
Inhal Toxicol. 2019, 31(13-14):432-445. doi: 10.1080/08958378.2019.1705441. Epub 2019 Dec 24. PMID: 31874579; PMCID: PMC6995422.

Estrous Cycle-Dependent Modulation of In Vivo Microvascular Dysfunction After Nanomaterial Inhalation.
Stapleton P., McBride C., Yi J., Abukabda A., and Nurkiewicz T.
Reproductive Toxicology. 2018, 78. DOI: 10.1016/j.reprotox.2018.03.001.

Maternal Engineered Nanomaterial Inhalation During Gestation Alters the Fetal Transcriptome. 
Stapleton P., Hathaway Q., Nichols C., Abukabda A., Pinti M., Shepherd D., McBride C., Yi J., Castranova V., Nurkiewicz T., and Hollander J.
Particle and Fibre Toxicology. 2018, 15:3 DOI 10.1186/s12989-017-0239-8.

Reactive Oxygen Species Damage Drives Cardiac and Mitochondrial Dysfunction Following Acute Nano-Titanium Dioxide Inhalation Exposure. 
Nichols C., Shepherd D., Thapa D., Yi J., Dabkowski E., Nurkiewicz T., and Hollander J.
Nanotoxicology. 2017, 12(1):32-48.

Heterogeneous Vascular Bed Responses to Pulmonary Titanium Dioxide Nanoparticle Exposure. 
Abukabda A., Stapleton P., McBride C., Yi J., and Nurkiewicz T. 
Front Cardiovasc Med. 2017, 4: 33.  https://doi.org/10.3389/fcvm.2017.00033. 

Characterization of Chemical Contaminants Generated by a Desktop Fused Deposition Modeling 3-Dimensional Printer. 
Stefaniak A., LeBouf R., Yi J.,Duling M., Nurkewicz T., Schwegler-Berry D., Chen B., and Virji A.
Journal of Occupational and Environmental Hygiene. 2017, 25:0. doi: 10.1080/15459624.2017.1302589.

Maternal-Engineered Nanomaterial Exposure Disrupts Progeny Cardiac Function and Bioenergetics. 
Hathaway Q., Nichols C., Shepherd D., Stapleton P., McLaughlin S., Stricker J., Rellick S., Pinti M., Abukabda A., McBride C., Yi J., Stine S., Nurkiewicz T., and Hollander J.
American Journal of Physiology - Heart and Circulatory Physiology. 2017, DOI: 10.1152/ajpheart.00634.2016.

Emission of Particulate Matter from a Desktop Three-Dimensional (3D) Printer. 
Yi J., LeBouf R., Duling M., Nurkiewicz T., Chen B., Schwegler-Berry D., Virji M., and Stefaniak A.
Journal of Toxicology and Environmental Health A. 2016, 79(11):453-65.

Impacts of Prenatal Nanomaterial Exposure on Male Adult Sprague-Dawley Rat Behavior and Cognition.
Engler-Chiurazzi E.B., Stapleton P.A., Stalnaker J.J., Ren X., Hu H., Nurkiewicz T.R., McBride C.R., Yi J., Engels K., and Simpkins J.W.
Journal of Toxicology and Environmental Health A. 2016, 79(11), 447–452.

Comparative Plasma Proteomic Studies of Pulmonary TiO2 Nanoparticle Exposure in Rats Using Liquid Chromatography Tandem Mass Spectrometry. 
Maurer M., Donohoe G., Maleki H., Yi J., McBride C., Nurkiewicz T., and Valentine S.
J Proteomics. 2016, 130:85-93.

Uterine Microvascular Sensitivity to Nanomaterial Inhalation: An In Vivo Assessment. 
Stapleton P., McBride C., Yi J., and Nurkiewicz T.
Toxicol Appl Pharmacol. 2015, 288(3):420-8. doi: 10.1016/j.taap.2015.08.013.

Microvascular and Mitochondrial Dysfunction in the Female F1 Generation After Gestational TiO2 Nanoparticle Exposure. 
Stapleton P., Nichols C., Yi J., McBride C., Minarchick V., Shepherd D., Hollander J., and Nurkiewicz T.
Nanotoxicology. 2015, Volume 9, Issue 8, pages 941-951.

A New Ion Mobility-Linear Ion Trap Instrument for Complex Mixture Analysis.
Donohoe G., Maleki H., Arndt J., Khakinejad M., Yi J., McBride C., Nurkiewicz T., and Valentine S.
Analytical Chemistry. 2014, 86(16):8121-8.

Whole-Body Nanoparticle Aerosol Inhalation Exposures.
Yi J., Chen B., Schwegler-Berry D., Frazer D., Castranova V., McBride C., Knuckles T., Stapleton P., Minarchick V., and Nurkiewicz T.
J Vis Exp. 2013, (75):e50263. doi:10.3791/50263.

Maternal Engineered Nanomaterial Exposure and Fetal Microvascular Function: Does the Barker Hypothesis Apply?
Stapleton P., Minarchick V., Yi J., Engels K., McBride C., and Nurkiewicz T.
American Journal of Obstetrics and Gynecology. 2013, 209(3):227.e1-11.

Nanoparticle Inhalation Alters Arteriolar Vasoreactivity through Sympathetic and Cyclooxygenase-Mediated Pathways. 
Knuckles T., Yi J., Frazer D., Leonard H., Chen B., Castranova V., and Nurkiewicz T.
Nanotoxicology. 2012, 6(7): 724-735. PMID: 21830860.

Dispersion of a Particle-Laden Air Jet in a Confined Rectangular Crossflow. 
Yi J. and Plesniak M.
Powder Technology. 2002, Vol. 125, pp. 168-178.

 

Lab Members

Contact information for all lab members:
(870) 543-7121
NCTRResearch@fda.hhs.gov

Seonggi Min, Ph.D.
Staff Fellow

Gregory Pellar, Ph.D.
Staff Fellow

Yunan Tang, Ph.D., DABT
Staff Fellow

Dong-Jin Yang, M.S.
Staff Fellow

Contact Information
Jinghai Yi
(870) 543-7121
Expertise
Expertise
Approach
Domain
Technology & Discipline
Toxicology
Back to Top